Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics

IRWD POWR Grades

• Quality is the dimension where IRWD ranks best; there it ranks ahead of 93.8% of US stocks.
• IRWD's strongest trending metric is Quality; it's been moving down over the last 177 days.
• IRWD ranks lowest in Sentiment; there it ranks in the 9th percentile.

IRWD Stock Summary

• With a one year PEG ratio of 0.34, IRONWOOD PHARMACEUTICALS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than merely 4.81% of US stocks.
• Of note is the ratio of IRONWOOD PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; just 3.59% of US stocks have a lower such ratio.
• Over the past twelve months, IRWD has reported earnings growth of -464.36%, putting it ahead of just 3.16% of US stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to IRONWOOD PHARMACEUTICALS INC are SM, MMAT, MRO, KOS, and ADV.
• IRWD's SEC filings can be seen here. And to visit IRONWOOD PHARMACEUTICALS INC's official web site, go to www.ironwoodpharma.com.

IRWD Valuation Summary

• IRWD's price/sales ratio is 3.4; this is 15% lower than that of the median Healthcare stock.
• Over the past 166 months, IRWD's price/sales ratio has gone down 28.8.

Below are key valuation metrics over time for IRWD.

IRWD Growth Metrics

Its 4 year cash and equivalents growth rate is now at 72.77%.
• The 5 year price growth rate now stands at -33.93%.
• Its 3 year cash and equivalents growth rate is now at 394.3%.

Over the past 34 months, IRWD's revenue has gone down $29,030,000.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	410.596	273.763	175.065
2022-09-30	420.527	259.149	167.572
2022-06-30	415.637	265.122	173.1
2022-03-31	422.437	252.325	527.323
2021-12-31	413.753	261.895	528.448
2021-09-30	413.303	248.84	530.278

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IRWD has a Quality Grade of B, ranking ahead of 94.53% of graded US stocks.
• IRWD's asset turnover comes in at 0.622 -- ranking 50th of 682 Pharmaceutical Products stocks.
• LGND, COLL, and OMER are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.